Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02122458 · ClinicalTrials.gov registry record · NA
Blast Exposed Veterans With Auditory Complaints
A NA study of Hearing Impairment and Hearing Aid Fitting, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- NA
- Development phase
- 363
- Enrollment target
- 3
- Study locations
NCT02122458: Completed NA study of Hearing Impairment and Hearing Aid Fitting, sponsored by VA Office of Research and Development.
NCT02122458 is a NA study of Hearing Impairment and Hearing Aid Fitting that has completed, run by VA Office of Research and Development. The registered enrollment target is 363 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (74% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02122458, a NA study of Hearing Impairment and Hearing Aid Fitting, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- NA
- Development phase
- 363 participants
- Enrollment target
- 3
- Study locations
Study Summary
The purpose of this study is to study blast-exposed Veterans who report hearing handicap but show normal or near normal results on standard audiometric testing. The characteristics and nature of their auditory and auditory-related skills will be examined, along with whether coexisting PTSD contributes to the hearing problems of these Veterans. In a preliminary treatment study, a sub-sample of these Veterans will be fitted with mild-gain hearing aids to determine if they benefit from low-level amplification of high-frequency sounds.
Primary Outcome
Self-perceived hearing handicap was measured with the Hearing Handicap Inventory for Adults (HHIA), pre- and 6-months post-hearing aid fitting. The minimum score is 0 and the maximum score is 100, with the higher score reflecting greater handicap (worse outcome). The data are presented as a comparison between the two questionnaire administrations (pre- and 6-months post-fitting). The null hypothesis tested was that there would be no difference between the HHIA administered at baseline (pre-fitti
Conditions Studied
Interventions
- DEVICE mild-gain hearing aids with high-frequency emphasis over 6-months
Study Locations (3)
Oregon
- VA Portland Health Care System, Portland, OR - Portland
Pennsylvania
- VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA - Pittsburgh
South Dakota
- Sioux Falls VA Health Care System, Sioux Falls, SD - Sioux Falls
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 363 participants |
| Start Date | 2015-08-01 |
| Est. Completion | 2020-12-31 |
| Phase | NA |
What the finished NCT02122458 record still lists
NCT02122458 is an interventional study that assigns participants to a tested intervention. The registered 363 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (74% lower).
The record links to 2 conditions, with Hearing Impairment appearing as the primary indexed condition, and to 1 intervention - of which mild-gain hearing aids with high-frequency emphasis over 6-months is the first listed.
NCT02122458 reports a single indexed study location in Oregon, Pennsylvania, South Dakota.
Frequently Asked Questions
What is clinical trial NCT02122458 about?
NCT02122458 is a clinical study titled "Blast Exposed Veterans With Auditory Complaints". The purpose of this study is to study blast-exposed Veterans who report hearing handicap but show normal or near normal results on standard audiometric testing. The characteristics and nature of their auditory and auditory-related skills will be examined, along with whether coexisting PTSD contribut...
What is the current status of trial NCT02122458?
This trial is currently completed. It is a NA study. The enrollment target is 363 participants. The study started on 2015-08-01. Estimated completion is 2020-12-31.
What conditions does trial NCT02122458 study?
This clinical trial studies the following conditions: Hearing Impairment, Hearing Aid Fitting.
What interventions are being tested in trial NCT02122458?
The interventions under investigation include: mild-gain hearing aids with high-frequency emphasis over 6-months (DEVICE).
Who is sponsoring clinical trial NCT02122458?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02122458 being conducted?
This trial has 3 study locations across Oregon, Pennsylvania, South Dakota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hearing Impairment
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02122458's enrollment target sits among peer trials
363 284th of 2000 higher than 1,717 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06472245 · 363 participants · Phase 3
Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor
- NCT04510597 · 364 participants · Phase 3
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
- NCT05098132 · 364 participants · Phase 1
Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers
- NCT05330221 · 364 participants · NA
Project 2: ACHIEVE- HF
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI